GSTA4 mediates reduction of cisplatin ototoxicity in female mice
A common complication of cisplatin-based chemotherapy is hearing loss. Here, Park et al. show that glutathione transferase α4 (GSTA4) contributes to reducing cisplatin toxicity in the inner ear of female mice by removing 4-hydroxynonenal (4-HNE).
Guardado en:
Autores principales: | Hyo-Jin Park, Mi-Jung Kim, Christina Rothenberger, Ashok Kumar, Edith M. Sampson, Dalian Ding, Chul Han, Karessa White, Kevin Boyd, Senthilvelan Manohar, Yong-Hwan Kim, Maria S. Ticsa, Aaron S. Gomez, Isabela Caicedo, Upal Bose, Paul J. Linser, Takuya Miyakawa, Masaru Tanokura, Thomas C. Foster, Richard Salvi, Shinichi Someya |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4b9d8b940ff4c42bbb2c14bdd319a1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
por: Chen Y, et al.
Publicado: (2019) -
Publisher Correction: The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity
por: Fabiola Paciello, et al.
Publicado: (2020) -
The analysis of GSTA1 promoter genetic and functional diversity of human populations
por: Vid Mlakar, et al.
Publicado: (2021) -
Auditory hypersensitivity and processing deficits in a rat model of fragile X syndrome
por: Benjamin D. Auerbach, et al.
Publicado: (2021) -
Nicotine induced ototoxicity in rat cochlear organotypic cultures
por: Zhao Yi, et al.
Publicado: (2021)